MP Materials Corp. — Q1 2024 Form 10-Q
Period: Three months ended March 31, 2024; comparisons are with Q1 2023 unless otherwise noted. MP Materials operates the Mountain Pass rare earth mine and processing facility and is expanding into separated products and magnet manufacturing.
Financial and operating performance
| Metric | Q1 2024 | Q1 2023 / comparison |
|---|---|---|
| Revenue | $48.7 million | $95.7 million; down 49% |
| Operating income (loss) | $(32.4) million | $33.0 million |
| Net income | $16.5 million | $37.4 million; down 56% |
| Adjusted EBITDA (non-GAAP) | $(1.2) million | $58.7 million |
| Operating cash flow | $(41.1) million | $55.5 million |
| Free cash flow (non-GAAP) | $(92.9) million | $(19.0) million |
| Capital expenditures | $51.8 million cash additions | $74.5 million |
| Cash, cash equivalents and short-term investments | $946.8 million | $997.8 million at Dec. 31, 2023 |
| Long-term debt, principal | $957.5 million | $690.0 million at Dec. 31, 2023 |
Basic EPS was $0.09 versus $0.21; diluted loss per share was $(0.08) versus diluted EPS of $0.20. Q1 2024 net income included a $46.3 million gain on extinguishing 2026 Notes. The quarter also included a $6.0 million inventory valuation reserve associated largely with early Stage II production.
Material changes and management commentary
- Rare earth concentrate revenue fell 58% to $40.1 million. Realized price declined 54% to $4,294 per REO metric ton, while REO sales volume fell 9% to 9,332 metric tons. Management attributed the price decline to a weak pricing environment and lower-than-anticipated growth in demand for magnetic products.
- NdPr oxide and metal sales, which were not present in the prior-year quarter, contributed $8.3 million. Production was 131 metric tons and sales were 134 metric tons. Management expects separated products to become a larger share of revenue as Stage II ramps, with concentrate sales correspondingly lower.
- Operating costs and expenses increased 29% to $81.1 million, including higher cost of sales and depreciation as facilities entered service. Start-up costs declined to $1.3 million from $4.7 million.
- Operating cash flow turned negative, primarily reflecting lower revenue and higher inventory to support commissioning and separated-product production. Cash and short-term investments declined by $51.1 million from year-end.
- In March, the company issued $747.5 million of 3.00% convertible notes due 2030, repurchased $480.0 million principal amount of 0.25% notes due 2026 for $428.6 million, and purchased capped calls for $65.3 million. It also repurchased 13.0 million shares for $200.8 million under a $300 million authorization; approximately $99.3 million remained available at quarter-end.
Outlook, risks and contingencies
- Management expects 2024 capital costs of $200 million to $250 million, including Fort Worth facility construction, the HREE facility, Upstream 60K and other Mountain Pass projects. It says available resources should fund near-term plans but cannot assure this.
- Stage II separated-product operations are still ramping; management expects it may take several quarters to reach designed throughput. Additional inventory reserves or project delays and cost increases remain possible.
- Shenghe accounted for more than 80% of Q1 revenue. Concentrate pricing depends partly on Shenghe’s realized resale prices and currency movements; sales are exposed to rare earth price volatility, China-related trade and policy risks, and customer concentration.
- A construction contractor dispute is scheduled for binding arbitration. The company cannot estimate a range of loss; an unfavorable outcome could be material when estimable.
- The company received a $58.5 million Section 48C tax-credit award for Fort Worth, but had recognized none of the credit at quarter-end. It is not eligible for direct pay, though transfer to an unrelated taxpayer may be elected.
- Convertible-note conversions could require cash settlement, affect liquidity or dilute shareholders. The capped calls are intended to mitigate some dilution, but expose the company to counterparty risk. Management reported disclosure controls were effective and no material changes in internal control over financial reporting.
Key facts for investors to verify
- Whether rare earth prices, concentrate sales volumes and demand recover, and how these affect realized prices and operating cash flow.
- Stage II ramp progress, unit costs and any further inventory write-downs; progress and spending on Fort Worth, HREE and Upstream 60K.
- Actual capital spending against the $200–$250 million 2024 expectation and the company’s liquidity needs as working capital grows.
- Terms and potential dilution or cash-settlement effects of the 2026 and 2030 convertible notes, and performance of the capped-call counterparties.
- Outcome and potential financial impact of the contractor arbitration, and realization or transfer value of the 48C credit.